Medline valuation
$39.09Change from previous close: −0.96%Absolute change: −$0.38
Valuation
The P/E ratio is 89.7. The average price target of 26 analysts is $45.35.
Data as of November 15, 2026
Medline compared with similar companies
Medline's P/E (trailing 12 months): 89.7, +108% against the median of a group of 9 similar companies (43.1).
| Metric | Medline | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 89.7 | 43.1 | 24.5 – 53.6 | High |
| Forward P/E | 25.5 | 17.5 | 13.5 – 30.5 | Middle |
| EV/EBITDA | 19.0 | 15.7 | 14.4 – 25.0 | Middle |
| Price/book | 2.94 | 2.94 | 2.23 – 5.27 | Middle |
| Price/sales | 1.69 | 2.85 | 1.77 – 7.21 | Low |
| Gross margin | 24.4% | 53.8% | 35.5% – 63.8% | Low |
| Operating margin | 5.4% | 12.9% | 7.8% – 21.3% | Low |
| Net margin | 1.8% | 5.9% | 1.9% – 16.1% | Low |
| ROE | 4.8% | 5.9% | 4.0% – 14.9% | Middle |
| Debt/equity | 0.65 | 0.48 | 0.16 – 0.66 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $51.94B
- Enterprise value
- $51.29B
- PEG
- 4.13
- EV/revenue
- 1.67
Profitability and growth
- ROA
- 2.7%
- ROIC
- 2.9%
- Revenue growth (year over year)
- 10.4%
- Earnings growth (year over year)
- 1,087.7%
Financial health
- Total cash
- $3.62B
- Total debt
- $12.65B
- Current ratio
- 4.04
- Quick ratio
- 2.37
- Altman Z-Score
- 2.18
- Piotroski F-Score
- 6.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $45.35
- Median price target
- $46.00
- High price target
- $55.00
- Low price target
- $34.00
- Analysts with a price target
- 26
- Consensus
- Buy
- Forward EPS
- $1.55
- EPS estimate, current year
- $1.56
Shares and trading
- Average volume
- 8.83M
- Shares outstanding
- 878.66M
- Float
- 382.03M
- Institutional ownership
- 112.8%
- Insider ownership
- 1.2%
- Short interest (% of float)
- 8.9%
- Short ratio (days)
- 4.20
